Shaw-Cheng Liu

494 total citations
8 papers, 409 citations indexed

About

Shaw-Cheng Liu is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Shaw-Cheng Liu has authored 8 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Shaw-Cheng Liu's work include Acute Myeloid Leukemia Research (4 papers), Protein Tyrosine Phosphatases (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Shaw-Cheng Liu is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Protein Tyrosine Phosphatases (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Shaw-Cheng Liu collaborates with scholars based in Singapore, United States and Japan. Shaw-Cheng Liu's co-authors include Wee Joo Chng, Jianbiao Zhou, Chonglei Bi, Siok‐Bian Ng, Keith B. Glaser, Chien-Shing Chen, Senthilnathan Palaniyandi, Lai-Fong Poon, Zhigang Xie and Daniel H. Albert and has published in prestigious journals such as Blood, Cancer Research and Molecular Cancer Research.

In The Last Decade

Shaw-Cheng Liu

7 papers receiving 405 citations

Peers

Shaw-Cheng Liu

MB

HEMAT

ONCOL

CR

IMMUN

Luke B. Fletcher United States

Yulei Shen United States

Rita Andraos Switzerland

Josephine L. Klitgaard United States

C Mitsiades United States

Adekunle Raji United States

Karl Hsu United States

Dina Ali Sweden

Tatjana Walther Germany

James Berenson United States

Luke B. Fletcher United States

Shaw-Cheng Liu

168 ×0.6

MB

121 ×1.0

HEMAT

64 ×0.7

ONCOL

51 ×0.7

CR

61 ×0.9

IMMUN

Citations per year, relative to Shaw-Cheng Liu Shaw-Cheng Liu (= 1×) peers Luke B. Fletcher

Countries citing papers authored by Shaw-Cheng Liu

Since Specialization

Citations

This map shows the geographic impact of Shaw-Cheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaw-Cheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaw-Cheng Liu more than expected).

Fields of papers citing papers by Shaw-Cheng Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaw-Cheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaw-Cheng Liu. The network helps show where Shaw-Cheng Liu may publish in the future.

Co-authorship network of co-authors of Shaw-Cheng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shaw-Cheng Liu. A scholar is included among the top collaborators of Shaw-Cheng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaw-Cheng Liu. Shaw-Cheng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Zhou, Jianbiao, Chonglei Bi, Phyllis S.Y. Chong, et al.. (2016). LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell–like Transcriptional Program in AML. Molecular Cancer Research. 15(3). 294–303. 30 indexed citations

2.

Chong, Phyllis S.Y., Jianbiao Zhou, Shaw-Cheng Liu, et al.. (2014). LEO1 Is Regulated by PRL-3 and Mediates Its Oncogenic Properties in Acute Myelogenous Leukemia. Cancer Research. 74(11). 3043–3053. 28 indexed citations

3.

Zhou, Jianbiao, Phyllis S.Y. Chong, Chonglei Bi, et al.. (2014). Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia. Experimental Hematology. 42(12). 1041–1052.e2. 21 indexed citations

4.

Yan, Junli, Siok‐Bian Ng, Bill Lin, et al.. (2013). EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity. Blood. 121(22). 4512–4520. 127 indexed citations

5.

Lee, Huiyin, Jianbiao Zhou, Shaw-Cheng Liu, et al.. (2010). Reduced plasma APOA1 level is associated with Gastric Tumor Growth in MKN45 mouse xenograft model. Journal of Proteomics. 73(8). 1632–1640. 54 indexed citations

6.

Zhou, Jianbiao, et al.. (2010). The Histone Methyltransferase Inhibitor, DZNep, Upregulates TXNIP, Increases ROS Production and Targets Leukemia Cells In AML. Blood. 116(21). 4355–4355. 10 indexed citations

7.

Zhou, Jianbiao, Chonglei Bi, Shaw-Cheng Liu, et al.. (2009). Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML. Blood. 113(17). 4052–4062. 139 indexed citations

8.

Zhou, Jianbiao, Chonglei Bi, Shaw-Cheng Liu, et al.. (2008). Identification of Core Gene Signature Associated with Synergism Between ABT-869, a FLT3 Inhibitor and SAHA, a HDAC Inhibitor in AML with FLT3-ITD Mutation.. Blood. 112(11). 1618–1618.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact